Ibrutinib in combination with revlimid/dexamethasone (RD) in relapsed/refractory multiple myeloma (AFT-15) Meeting Abstract


Authors: Efebera, Y.; Suman, V. J.; Dinner, S. N.; Rosko, A. E.; McKay, J. T.; Barth, P.; Hagen, P.; Usmani, S. Z.; Richardson, P. G.; Laubach, J. P.
Abstract Title: Ibrutinib in combination with revlimid/dexamethasone (RD) in relapsed/refractory multiple myeloma (AFT-15)
Meeting Title: 65th Annual Meeting of the American Society of Hematology (ASH)
Journal Title: Blood
Volume: 142
Issue: Suppl. 1
Meeting Dates: 2023 Dec 9-12
Meeting Location: San Deigo, CA
ISSN: 0006-4971
Publisher: American Society of Hematology  
Date Published: 2023-11-02
Start Page: 3340
Language: English
ACCESSION: WOS:001159740303203
DOI: 10.1182/blood-2023-187296
PROVIDER: wos
Notes: Meeting Abstract -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Saad Zafar Usmani
    296 Usmani